Form 4: Ionis Pharmaceuticals Executive Exercises Stock Options and Sells Shares for Tax Obligations

EVP and Chief Business Officer of Ionis Pharmaceuticals, Joseph Baroldi, reports exercising stock options and selling shares to cover tax obligations.

Summary

• On April 15, 2024, Joseph Baroldi, EVP and Chief Business Officer of Ionis Pharmaceuticals, exercised restricted stock units, acquiring 10,838 shares of common stock.
• These shares were acquired through the vesting and release of shares from a Restricted Stock Unit award.
• On April 16, 2024, Baroldi sold 4,006 shares of common stock at a weighted average price of $41.5978 per share.
• The sale was executed to cover required tax withholding obligations related to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
• Following these transactions, Baroldi directly owns 19,631 shares of common stock and indirectly owns 1,640 shares through a spouse.

Sentiment

Score: 5

Explanation: The document reflects routine executive stock transactions, which are neither particularly positive nor negative.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation and tax planning. The Form 4 filing provides transparency into these transactions.

Key Dates